Homozygous familial hypercholesterolemia

被引：1
|
作者：
Wierzbicki, Anthony S. [1 ,2 ]
机构：
[1] Guys Hosp, London SE1 7EH, England
[2] St Thomas Hosp, London SE1 7EH, England
来源：
CLINICAL LIPIDOLOGY | 2013年 / 8卷 / 04期
关键词：
antisense oligonucleotide; apheresis; coronary artery disease; familial hypercholesterolemia; homozygous; microsomal transfer protein inhibitor; xanthoma; LIPOPROTEIN APHERESIS; EFFICACY; ATORVASTATIN; DIAGNOSIS; PROTEIN; TRIAL;
D O I：
10.2217/CLP.13.37
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Evaluation of: Rocha VZ, Chacra AP, Salgado W et al. Extensive xanthomata and severe subclinical atherosclerosis in homozygous familial hypercholesterolemia. J. Am. Coll. Cardiol. 61(21), 2193 (2013).This paper evaluation summarizes a case report of homozygous familial hypercholesterolemia. The patient in this particular case presented with gross xanthomata, elevated LDL cholesterol and extant coronary arterial disease in early adulthood. The clinical diagnosis, physical signs and management of the condition are discussed and future treatment options for homozygous familial hypercholesterolemia are reviewed.
引用
收藏
页码：407 / 409
页数：3
相关论文
共 50 条
  • [41] Managing Patients With Homozygous Familial Hypercholesterolemia
    Gidding, Samuel S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (09) : 1171 - 1172
  • [42] Multimodal Treatment of Homozygous Familial Hypercholesterolemia
    Gossios, Thomas
    Zografou, Ioanna
    Simoulidou, Veta
    Pirpassopoulou, Athina
    Christou, Konstantinos
    Karagiannis, Asterios
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (31) : 3616 - 3621
  • [43] CUTANEOUS XANTHOMAS IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    TERUEL, JL
    LASUNCION, MA
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (17): : 1137 - 1137
  • [44] Aortic hypoplasia in homozygous familial hypercholesterolemia
    Jones, E
    Feverstein, IM
    Tucker, E
    Summers, RM
    Spray, TI
    Hoeg, JM
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (10): : 1242 - +
  • [45] Lomitapide for the Management of Homozygous Familial Hypercholesterolemia
    deGoma, Emil M.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2014, 15 (02) : 109 - 118
  • [46] ATYPICAL PHENOTYPE OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Kyselak, Ondrej
    Freiberger, Tomas
    Kovar, Jan
    Tichy, Lukas
    Soska, Vladimir
    ATHEROSCLEROSIS, 2017, 263 : E224 - E224
  • [47] Evinacumab for Homozygous Familial Hypercholesterolemia REPLY
    Raal, Frederick J.
    Gaudet, Daniel
    Gusarova, Viktoria
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (06):
  • [48] Apheresis in homozygous familial hypercholesterolemia: The results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia
    Graesdal, Asgeir
    Bogsrud, Martin Proven
    Holven, Kirsten Bjorklund
    Nenseter, Marit S.
    Narverud, Ingunn
    Langslet, Gisle
    Brekke, Magne
    Retterstol, Kjetil
    Arnesen, Kjell-Erik
    Ose, Leiv
    JOURNAL OF CLINICAL LIPIDOLOGY, 2012, 6 (04) : 331 - 339
  • [49] Homozygous familial hypercholesterolemia: A study of 36 cases with phenotype of homozygous familiar hypercholesterolemia in Colombia
    Ruiz, A.
    Patino, L. F.
    Amaya, K. J.
    Gomez, J. E.
    Ordonez, F.
    Paternina, S.
    Mercado, M.
    Pachajoa, H.
    Campo, R.
    Coll, M.
    Jimenez, R.
    Matallana, A.
    Zuluaga, N.
    Toro, J. M.
    Rivera, C.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1304 - 1304
  • [50] LIVER TRANSPLANTATION AS A TREATMENT FOR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Kanmaz, Turan
    Yankol, Yucel
    Karatas, Cihan
    Mecit, Nesimi
    Orug, Taner
    Acarli, Koray
    Kalayoglu, Munci
    PEDIATRIC TRANSPLANTATION, 2011, 15 : 97 - 97
12345